1. Search Result

Search Result

Targets Recommended: MEK

Results for "Allosteric mek Inhibitors" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-12062

    MEK Cancer
    PD318088 is an allosteric MEK inhibitor.
  • HY-14691

    BAY 869766; RDEA119

    MEK Cancer
    Refametinib (BAY 869766; RDEA119) is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor with IC50s of 19 nM and 47 nM, respectively.
  • HY-12042

    AS703026; MSC1936369B

    MEK Cancer
    Pimasertib (AS703026) is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2, used for cancer treatment.
  • HY-13449

    MEK Cancer
    TAK-733 is a potent and selective MEK allosteric site inhibitor with an IC50 of 3.2 nM.
  • HY-18652
    Ro 5126766


    MEK Raf Cancer
    Ro 5126766 is a first-in-class dual MEK/RAF inhibitor that allosterically inhibits BRAF V600E, CRAF, MEK, and BRAF (IC50: 8.2, 56, 160 nM, and 190 nM, respectively).